Prednisone vs Prednisolone

In patients with normal liver function, prednisone and prednisolone are considered bioequivalent and therapeutically interchangeable ^[3][5]. After oral administration of prednisone, hepatic conversion to prednisolone occurs rapidly, with peak prednisolone levels reached within 1-2 hours ^[3]. Studies measuring area under the curve (AUC) for prednisolone after administration of equivalent doses of either drug show no clinically significant difference in healthy volunteers or patients with normal hepatic function ^[5].

The clinical efficacy of both drugs has been demonstrated across the full spectrum of corticosteroid-responsive conditions. Both are FDA-approved for allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders ^[1][2]. Anti-inflammatory potency is identical on a milligram-for-milligram basis (5 mg prednisone = 5 mg prednisolone), with both rated at 4 times the potency of hydrocortisone ^[4][5].

In patients with severe hepatic impairment (cirrhosis, liver failure), the conversion of prednisone to prednisolone may be significantly reduced, potentially leading to subtherapeutic drug levels ^[3][6]. Studies in cirrhotic patients have shown decreased and delayed conversion, with reduced AUC for prednisolone after prednisone administration compared to direct prednisolone administration ^[6]. In these patients, prednisolone is preferred to ensure reliable drug exposure ^[3][6].

In pediatric practice, particularly for infants and young children, prednisolone is often preferred because of available liquid formulations that provide more accurate dosing for small patients ^[7]. Additionally, some clinicians prefer prednisolone in critically ill patients where hepatic blood flow may be compromised, though evidence for a clinically meaningful difference in this population is limited ^[3].

Because prednisone is converted to prednisolone before exerting its pharmacological effects, the side effect profiles of both drugs are essentially identical ^[1][2][5]. Both carry the full spectrum of corticosteroid adverse effects, which are primarily dose-dependent and duration-dependent rather than specific to either drug.

Short-term use (less than 2 weeks) commonly causes insomnia, increased appetite, weight gain, mood changes (euphoria, irritability, or anxiety), fluid retention, elevated blood glucose, and dyspepsia ^[1][2]. These effects are generally reversible upon discontinuation. A large retrospective cohort study found that even short courses of corticosteroids were associated with increased rates of sepsis (incidence rate ratio 5.30), venous thromboembolism (IRR 3.33), and fracture (IRR 1.87) within 30 days ^[8].

Long-term use (weeks to months) introduces more serious adverse effects including osteoporosis and fracture risk, adrenal suppression, Cushing syndrome (moon face, buffalo hump, central obesity), cataracts, glaucoma, hyperglycemia or new-onset diabetes, skin thinning and easy bruising, impaired wound healing, increased susceptibility to infections, and myopathy ^[1][2][4]. The risk of osteoporosis is significant enough that guidelines recommend bone density monitoring and prophylactic calcium/vitamin D supplementation (and sometimes bisphosphonates) for patients expected to take corticosteroids for more than 3 months ^[4][9].

Adrenal suppression occurs with both drugs after prolonged use, necessitating gradual tapering rather than abrupt discontinuation to avoid adrenal crisis ^[1][2]. The hypothalamic-pituitary-adrenal (HPA) axis may take weeks to months to recover after prolonged corticosteroid therapy. There is no evidence that one drug causes more or fewer side effects than the other at equivalent doses ^[5].

Both prednisone and prednisolone are available as inexpensive generics, though prednisone is generally the less expensive option in the United States ^[10]. Generic prednisone tablets (5 mg, 10 mg, 20 mg) typically cost $3-$10 for a 30-day supply at retail pharmacies. Generic prednisolone tablets are similarly affordable at $5-$15 per month ^[10].

Prednisolone oral solution (15 mg/5 mL) and prednisolone sodium phosphate oral solution (used extensively in pediatrics) are moderately more expensive at $15-$40 per bottle, depending on pharmacy and volume ^[10]. Prednisone oral solution is less commonly stocked but is available at similar pricing.

Both drugs are universally covered by insurance plans with no prior authorization requirements. For cost-sensitive patients with normal liver function, prednisone tablets offer a slight cost advantage. When a liquid formulation is required (pediatric dosing, patients who cannot swallow tablets), prednisolone solution is the standard choice and is readily available at most pharmacies.

Both drugs are taken orally, typically once daily in the morning to mimic the body's natural cortisol rhythm, or in divided doses for higher total daily doses ^[1][2]. Dosing is identical on a milligram-for-milligram basis, requiring no conversion calculations when switching between them ^[5].

Prednisone is available as tablets in a wider range of strengths (1, 2.5, 5, 10, 20, 50 mg) and as a convenience-packed dose taper (Dosepak) for short-course therapy ^[1]. Prednisolone is available as tablets (5 mg), orally disintegrating tablets (10, 15, 30 mg), and multiple oral solution formulations including prednisolone sodium phosphate solution and prednisolone base syrup ^[2][7].

The liquid formulations of prednisolone give it a practical advantage in pediatrics, where precise weight-based dosing is essential and many children cannot swallow tablets ^[7]. Prednisolone solutions are generally better-tasting than prednisone solutions, which has meaningful implications for adherence in young children. Prednisone's dose-pack formulation simplifies tapering schedules for conditions like acute asthma exacerbations or allergic reactions, as the pre-packaged taper eliminates dosing confusion ^[1].

For the majority of adult patients with normal liver function, prednisone and prednisolone are therapeutically interchangeable, and the choice between them is largely a matter of prescribing convention and cost ^[3][5]. Prednisone is more commonly prescribed in the United States simply because of long-standing tradition and slightly lower cost, while prednisolone is preferred in the United Kingdom and Australia ^[5].

Prednisolone should be specifically chosen over prednisone in patients with significant liver disease (cirrhosis, hepatic failure, or severely compromised hepatic function) where the conversion of prednisone to prednisolone may be impaired ^[3][6]. It is also preferred in infants and young children because of the availability of palatable liquid formulations that allow precise weight-based dosing ^[7].

For patients on complex medication regimens, both drugs have similar drug interaction profiles because the active moiety is the same (prednisolone). Both interact with CYP3A4 inducers and inhibitors, and both can affect warfarin metabolism, blood glucose levels, and the efficacy of vaccines ^[1][2][4].

Some transplant centers have institutional protocols preferring prednisolone in the immediate post-transplant period when hepatic function may be unpredictable, though evidence for this practice is limited ^[6]. If you are prescribed either medication, the most important considerations are proper dosing, appropriate duration, gradual tapering when indicated, and monitoring for side effects — not which specific form of corticosteroid was chosen. Discuss any concerns with your prescribing physician.